Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Docosanoids [FA04]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04010398 ent-4-A4-NeuroP (R,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010399 4-A4-NeuroP (S,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010400 ent-4,7-diepi-4-A4-NeuroP (S,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010401 7-epi-4-A4-NeuroP (S,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010402 ent-4-epi-4-A4-NeuroP (S,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010403 7-epi-7-A4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010404 ent-10-epi-7-A4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010405 7,10-diepi-7-A4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010406 ent-7-A4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010407 7-A4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010408 ent-7,10-diepi-7-A4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010409 10-epi-7-A4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010410 ent-7-epi-7-A4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010411 10-epi-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010412 ent-13-epi-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010413 10,13-diepi-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010414 ent-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010415 10-A4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010416 ent-10,13-diepi-10-A4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010417 13-epi-10-A4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010418 ent-10-epi-10-A4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010419 11-epi-11-A4-NeuroP 3-((1R,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010420 ent-4-epi-11-A4-NeuroP 3-((1R,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010421 4,11-diepi-11-A4-NeuroP 3-((1S,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010422 ent-11-A4-NeuroP 3-((1S,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010423 11-A4-NeuroP 3-((1R,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010424 ent-4,11-diepi-11-A4-NeuroP 3-((1R,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010425 4-epi-11-A4-NeuroP 3-((1S,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010426 ent-11-epi-11-A4-NeuroP 3-((1S,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010427 13-epi-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010428 ent-16-epi-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010429 13,16-diepi-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010430 ent-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010431 13-A4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010432 ent-13,16-diepi-13-A4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010433 16-epi-13-A4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010434 ent-13-epi-13-A4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010435 14-epi-14-A4-NeuroP (Z)-6-((1R,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010436 ent-7-epi-14-A4-NeuroP (Z)-6-((1R,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010437 7,14-diepi-14-A4-NeuroP (Z)-6-((1S,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010438 ent-14-A4-NeuroP (Z)-6-((1S,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010439 14-A4-NeuroP (Z)-6-((1R,2R)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010440 ent-7,14-diepi-14-A4-NeuroP (Z)-6-((1R,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010441 7-epi-14-A4-NeuroP (Z)-6-((1S,2R)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010442 ent-14-epi-14-A4-NeuroP (Z)-6-((1S,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010443 17-epi-17-A4-NeuroP (4Z,7Z)-9-((1R,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010444 ent-10-epi-17-A4-NeuroP (4Z,7Z)-9-((1R,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010445 10,17-diepi-17-A4-NeuroP (4Z,7Z)-9-((1S,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010446 ent-17-A4-NeuroP (4Z,7Z)-9-((1S,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010447 17-A4-NeuroP (4Z,7Z)-9-((1R,2R)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid FA 22:7;O2 C22H30O4 358.214410